Advanced wireless technologies and novel approaches to DM therapeutics that once were unimaginable continue to refine diabetes management.
Image ©Sergey Nivens/Shutterstock.com
5 Top Apps for Diabetes Caregivers
ShugaTrak, Glucose Buddy, OnTrack -- 3 of the 5 apps we highlight that are designed to make diabetes monitoring seamless for all.
Intensive Rx Similar to Standard Care for Preventing CV Events in T2D
More intensive reduction of A1c, lipids, and blood pressure did, however, result in a significantly reduced rate of cerebrovascular events.
True or False: Diabetes, Anxiety, and Depression
What's true and what's false about the connections between these often comorbid conditions? These 10 statements will test what you know.
Statins Up Risk for Diabetes in High-Risk Patients
Data from the DPP Outcomes Study reveal a greater than 25% increase in risk for diabetes in this already vulnerable population.
5 New Diabetes Technologies for Patient Empowerment
Five slides, 5 snapshots of products that help reduce fingerstick anxiety, enhance medication adherence, and prevent plantar ulcers.
Afib and T1D: Linked by Cause or Correlation?
A recent study, the first of its kind, reports an association between T1DM and AF, and between glycemic control and AF. Plus, there are interesting gender differences.
Video: When Should Metformin be Omitted?
Guidelines say metformin should be stopped where there is acute kidney injury or risk of renal compromise. Now there is evidence to support those recommendations.
Video: How to Follow an Adrenal Incidentaloma
To image or not to image: A new study validates professional society recommendations on follow-up strategies for adrenal masses.
AACE/ACE Focus on Lipids: 2017 Consensus Guidelines
The AACE/ACE 2017 recommendations on lipid management renew focus on LDL-C targets, and go far lower than any group has ventured to date.
SGLT2 Inhibitor Offers CV, Renal Protection in High-risk Patients
Significant reductions were seen in MACE, renal disease progression in patients with high CV risk taking canagliflozin.